HIV-1 Current Events | HIV-1 News | 5
|
| Page
5 of
35 |
687 Results |
|
|
|
Sort By:
Page Views | Date |
Tuberculosis Still a Risk for Patients Receiving HIV Drugs
People taking highly active antiretroviral therapy (HAART) for HIV infection remain susceptible to tuberculosis, though the risk is lower than for HIV-infected patients not on HAART. view more (2005-11-14)
'POZ parties' signal potential to spread HIV 'superinfection'
The emergence of "POZ Parties"-parties exclusively for HIV positive men to meet other HIV positive men for sex-signals the potential to spread HIV "superinfection,"suggests research in Sexually Transmitted Infections. view more (2005-09-29)
Can periodontal disease act as a risk factor for HIV-1?
Today, during the 87th General Session of the International Association for Dental Research, convening at the Miami Beach Convention Center, a group of scientists from Nihon University (Tokyo, Japan) will present findings suggesting that periodontal disease could act as a risk factor for reactivating latent HIV-1 in affected individuals. view more (2009-04-03)
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Cytomegalovirus infection still associated with poor HIV/AIDS prognosis (p 2101, 2116)
Results of a UK study in this week's issue of THE LANCET highlight how the treatment of cytomegalovirus infection remains a priority in order to improve the prognosis for people with HIV-1 infection, including people already receiving antiretroviral therapy. The advent of highly active antiretroviral therapy (HAART) at the end of the 20th century... view more... (2004-06-23)
Having a stable partner delays AIDS in HIV patients
For people with HIV, having a stable partner is associated with slower rate of progression to AIDS or death, finds a study in this week's BMJ. Researchers in Switzerland followed 3,736 adults with HIV who had started highly active antiretroviral therapy (HAART) before 2002. Every six months, patients were asked whether they had had sexual... view more... (2004-01-03)
Study suggests life insurance should cover people treated for HIV (p 877)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. Authors of a Swiss study in this week's issue of THE LANCET highlight how people effectively treated for HIV-1 infection with highly active antiretroviral therapy (HAART) have similar or lower mortality rates than patients successfully treated for cancer-calling into... view more... (2003-09-10)
Study Suggests Potential Of Low-cost Options For Monitoring Disease Status In Hiv-1-Infected Children In Less-developed Countries (pp 1597, 1625)
Authors of a research letter in this week's issue of THE LANCET highlight how assessment of total blood lymphocyte count and albumen concentrations could have potential as low-cost alternatives in assessing the disease status of HIV-1-infected children in less-developed countries. The cost of laboratory analysis of CD4 lymphocyte count and... view more... (2003-11-12)
Should we test for HIV status in pregnant women?
Dr Lorraine Sherr, Professor Chris Hudson, and colleagues from several UK and European medical schools, have been studying the way other European countries are handling the problem, and found that the major variations between countries reflect the complexity of the ethics involved. view more (1999-06-03)
Routine HIV screening in the ED is cost effective and well liked by patients
Using the new and highly publicized CDC guidelines for HIV screening, a university-based Emergency Department implemented opt-out screening in Washington, DC, where HIV infection rates are known to be high. view more (2007-05-16)
Risk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures. view more (2008-08-29)
Three out of four junior doctors risk potential HIV infection during course of work
Three out of four junior doctors are at potentially high risk of HIV infection at some time during their careers, shows a survey in Sexually Transmitted Infections. Yet two thirds were unaware that they could be treated immediately afterwards to minimise the risk of infection. view more (2001-11-20)
HIV isolate from Kenya provides clues for vaccine design
Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine. view more (2008-01-03)
Malaria may fuel spread of HIV in sub-Saharan Africa
Malaria may be fueling the spread of HIV in areas of sub-Saharan Africa where there is a substantial overlap between the two diseases, while HIV may be playing a role in boosting adult malaria-infection rates in some parts of the region, according to a new study by researchers at Fred Hutchinson Cancer Research Center and the University of... view more... (2006-12-08)
New therapies mean HIV patients gain longer lives, face new challenges
New HIV therapies have prolonged lives and improved health for patients with HIV, but the treatments have also brought the longer-term effects of the disease into sharper focus. view more (2009-05-18)
Keeping young South Africans in school: A 'social vaccine' against AIDS
A study published today in the Journal of Epidemiology and Community Health suggests that secondary school attendance is linked to lower risk of HIV infection among young people in rural South Africa. view more (2008-01-17)
Breastfeeding now safer for infants of HIV-infected mothers
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding. view more (2008-02-05)
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. view more (2009-11-06)
HIV-1 : RECOMBINATION BETWEEN TWO STRAINSFROM WIDELY DISTANT GROUPS
Scientists have known for a long time that the AIDS virus is genotypically highly variable. Two main types of the virus exist: HIV-1 and HIV-2. HIV-1, the most widespread throughout the world, can be divided into three groups (M, N and O) each of which has different genetic characteristics. Within group M, which gathers together the most frequent... view more... (2000-03-09)
Scientists glimpse a rare human antibody which protects against AIDS
Scientists have obtained their first detailed glimpse of a rare antibody, called b12, which is capable of inactivating many different strains of HIV, the virus which causes AIDS. A crystal structure of b12 has been determined by scientists working at The Scripps Research Institute, California, and the Glycobiology Institute at Oxford University,... view more... (2001-08-08)
|
|
| Page
5 of
35 |
687 Results |
|
|
|
Sort By:
Page Views | Date |
|
